Given that VCAN regulates the AP-1 transcriptional activator, thereby influencing cell proliferation and migration, we explored the possibility of disrupting VCAN-mediated glioma progression by directly inhibiting the PI3K/Akt pathway, as no specific inhibitor for VCAN currently exists. The gene discussed is JUN; the disease is central nervous system cancer.